- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Market share of generics in European countries 2016
Market share of generics in European countries 2016
Market share of generics in selected European countries as of 2016
This statistic displays the share of generics in the pharmaceutical market sales value in Europe by selected countries in 2016. The generic share in the pharmaceutical industry's market sales in Denmark exceeded 30 percent in 2016. Market share of generics is higher in newer EU member states due to low levels of intellectual property protection.
Market share of generics in selected European countries as of 2016
Loading statistic...
Expand statistic
| Share of pharmaceutical market sales value | |
|---|---|
| Poland | 60.4% |
| Russia | 57% |
| Italy | 56.1% |
| Bulgaria | 47% |
| Croatia | 42% |
| Austria | 40.6% |
| Turkey | 39.2% |
| Hungary | 37.6% |
| Germany | 30.8% |
| Denmark | 30.5% |
| United Kingdom | 29% |
| Romania | 28.1% |
| Slovenia | 25.5% |
| Finland | 24.2% |
| Greece | 23.4% |
| Spain | 22.1% |
| Portugal | 22% |
| France | 19.6% |
| Ireland | 19% |
| Estonia | 18.9% |
| Sweden | 18.6% |
| Netherlands | 17.2% |
| Belgium | 16.6% |
| Switzerland | 13.5% |
| Share of pharmaceutical market sales value | |
|---|---|
| Poland | 60.4% |
| Russia | 57% |
| Italy | 56.1% |
| Bulgaria | 47% |
| Croatia | 42% |
| Austria | 40.6% |
| Turkey | 39.2% |
| Hungary | 37.6% |
| Germany | 30.8% |
| Denmark | 30.5% |
| United Kingdom | 29% |
| Romania | 28.1% |
| Slovenia | 25.5% |
| Finland | 24.2% |
| Greece | 23.4% |
| Spain | 22.1% |
| Portugal | 22% |
| France | 19.6% |
| Ireland | 19% |
| Estonia | 18.9% |
| Sweden | 18.6% |
| Netherlands | 17.2% |
| Belgium | 16.6% |
| Switzerland | 13.5% |
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic displays the share of generics in the pharmaceutical market sales value in Europe by selected countries in 2016. The generic share in the pharmaceutical industry's market sales in Denmark exceeded 30 percent in 2016. Market share of generics is higher in newer EU member states due to low levels of intellectual property protection.
Show more- Show sources information
- Show publisher information
- Release date
- June 2018
- Region
- Europe
- Survey time period
- 2016
- Supplementary notes
-
EFPIA: European Federation of Pharmaceutical Industries and Associations
Croatia, Denmark, Estonia, Finland, Greece, United Kingdom: share of generics in pharmacy market sales. Austria, Belgium, Bulgaria, France, Germany, Ireland, Italy, Netherlands, Portugal, Slovenia, Spain: share of generics in reimbursable pharmacy market sales. Czech Republic, Poland, Romania, Russia, Sweden, Switzerland, Turkey: share of generics in total market sales. Cyprus, Hungary, Iceland, Latvia, Lithuania, Malta, Norway, Serbia, Slovakia: 2016 data not available. France: data relate only to those active substances listed on the official list of medicines.
Source
- Show sources information
- Show publisher information
- Release date
- June 2018
More information
- Region
- Europe
- Survey time period
- 2016
- Supplementary notes
-
EFPIA: European Federation of Pharmaceutical Industries and Associations
Croatia, Denmark, Estonia, Finland, Greece, United Kingdom: share of generics in pharmacy market sales. Austria, Belgium, Bulgaria, France, Germany, Ireland, Italy, Netherlands, Portugal, Slovenia, Spain: share of generics in reimbursable pharmacy market sales. Czech Republic, Poland, Romania, Russia, Sweden, Switzerland, Turkey: share of generics in total market sales. Cyprus, Hungary, Iceland, Latvia, Lithuania, Malta, Norway, Serbia, Slovakia: 2016 data not available. France: data relate only to those active substances listed on the official list of medicines.
Other statistics on the topic
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Pharmaceutical trends in Europe
- 85 page/s
- English
- pptx
- Detailed references
Everything On "Pharmaceutical trends in Europe" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Pharmaceutical trends in Europe"
- Overview
The most important statistics
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)Turnover of leading European pharmaceutical markets 2017
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)Turnover of pharmaceutical markets in Central and Eastern Europe 2017
- Share of breakdown of pharmaceutical price structure in Europe in 2016*Pharmaceutical price structure breakdown in Europe 2016
- Value Added Tax (VAT) rate on over-the-counter (OTC) drugs in Europe in 2018, by country*VAT rate on over-the-counter drugs in Europe 2018, by country
- Value Added Tax (VAT) rate on prescription-only drugs in Europe in 2018, by countryVAT rate on prescription-only drugs in Europe 2018
- Share of GDP expenditure on research and development in the EU-28 countries from 2000 to 2015*European Union: share of GDP expenditure on research and development 2000-2015
- Pharmaceutical research and development spending in selected European countries in 2016 (in million euros)Research and development in European pharmaceutical industry by country 2016
- Annual growth of pharmaceutical R&D spending in Europe and the U.S. between 2003 and 2017Yearly growth rate of R&D spending in pharmaceutical industry 2003-2017
- European Pharmaceutical companies
The most important statistics
- Leading 18 European pharmaceutical companies by retail sales in 2015 (in billion U.S. dollars)Leading 18 European pharmaceutical companies by retail sales 2015
- Leading pharmaceutical and biotechnology companies in Europe in 2015, based on market value (in million U.S. dollars)Leading European pharmaceutical & biotechnology companies ranked by market value 2015
- Leading European pharmaceutical companies by spending on research and development in 2015 (in million U.S. dollars)Leading European pharmaceutical companies by R&D spending 2015
- Leading European pharmaceutical companies by investment in research and development in 2014 (in million U.S. dollars)Leading European pharmaceutical companies by R&D investment 2014
- Pharmaceutical production value of EFPIA members from 1990 to 2017 (in million euros)Members of EFPIA's pharmaceutical production value 1990-2017
- Pharmaceutical research and development spending of EFPIA members from 1990 to 2017 (in million euros)Members of EFPIA's pharmaceutical R&D spending 1990-2017
- Self-medication market
The most important statistics
- Sales in the self-medication market in selected European countries in 2017 (in million euro)Self-medication market sales in Europe in 2017, by country
- Sales of analgesics in the self-medication market in Europe in 2017, by country (in million euro)Self-medication market sales of analgesics in Europe in 2017, by country
- Sales of cough and cold products in the self-medication market in Europe in 2017, by country (in million euro)Cough and cold self-medication market sales in Europe in 2017
- Sales of digestives and intestinal remedies in the self-medication product market in Europe in 2017, by country (in million euro)Digestives and intestinal remedies self-medication market sales in Europe 2017
- Sales of self-medication skin treatment products in Europe in 2017, by country (in million euros)Self-medication skin treatment product sales in Europe 2017, by country
- Sales of vitamin and mineral products in the self medication market in Europe in 2017, by country (in million euro)Self-medication: sales of vitamins and minerals in Europe 2017
- Market value of self-medication drugs in Italy from 2014 to 2017 (in million euros)Italy: market value of self-medication drugs 2014-2017
- Sales revenue of self-care medicines in the Netherlands in 2017, by purchase channel (in million euros)Sales revenue of self-care medicines in the Netherlands 2017, by purchase channel
- Employment
The most important statistics
- Pharmaceutical employment in selected European countries in 2016Employment in European pharmaceutical industry by country 2016
- Total pharmaceutical employment in EFPIA countries from 1990 to 2017Employment in EFPIA pharmaceutical industry 1990-2017
- Employment in pharmaceutical products and preparations manufacturing in the United Kingdom from 2008 to 2017 (in 1,000s)Pharmaceutical manufacturing employment in the United Kingdom 2008-2017
- Number of employees in biotechnology companies, split by private or public sector in Switzerland from 2012 to 2017Switzerland: number of employees in biotech companies 2012-2017
- Number of employees in the pharmaceutical industry in Germany from 2010 to 2016Pharmaceutical industry: number of employees in Germany 2010-2016
- Number of employees in the pharmaceutical industry in Belgium from 2014 to 2017Number of employees in the pharmaceutical industry in Belgium 2014-2017
- Number of employees of pharmaceutical companies in France in 2014, by region of residenceNumber of employees of pharmaceutical companies by region France 2014
- Number of employees in the pharmaceutical industry in Italy between 2000 and 2017Italy: number of employees in the pharmaceutical industry 2000-2017
- Clinical Trials
The most important statistics
- Distribution of European clinical and phase III pipeline in 2013, by indicationDistribution of European clinical and phase III pipeline 2013 by indication
- Number of clinical trials submitted to the European Medicines Agency from European countries from 2005 to 2011Pivotal trials submitted to the European Medicines Agency from Europe 2005-2011
- Number of patients per clinical trial in selected European countries from 2005 to 2011Patients in clinical trials in selected European countries 2005-2011
- Number of applications to conduct a clinical trial submitted to BfArM and PEI* in Germany from 2009 to 2017Clinical trial conduct applications in Germany 2009-2017
- Number of clinical trials authorized by the competent authority in Italy from 2003 to 2017Italy: number of clinical trials authorized in Italy 2003-2017
Popular Related Keywords
- pharmaceutical
- Pharmaceutical companies
- generic
- market research
- pharmaceutical products
- Biopharmaceuticals
- pharmaceutical distributor
- annual production
- generic drug
- pharmaceutical markets
- pharmaceutical industry
- pharmaceutical revenue
- generics market
- pharmaceutical expenditure
- world pharmaceutical market
- European pharmaceutical market
- knowledge research
- country shares
- pharmaceutical manufacturers
- pharmaceutical data
- pharmaceutical business
- pharmaceutical market
- country share
- biopharma industry
- pharmaceutical imports
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Revenue of generic pharmaceutical manufacturing in the U.S., 2008-2013
- Share value of the generic pharmaceuticals market in Portugal 2000-2017
- Share value of the generic pharmaceuticals market in Czechia 2001-2016
- Share value of the generic pharmaceuticals market in Slovakia 2000-2016
- Share value of the generic pharmaceuticals market in Switzerland 2000-2017
- Share value of the generic pharmaceuticals market in Turkey 2008-2016
- Share value of the generic pharmaceuticals market in Estonia 2006-2017
- Share value of the generic pharmaceuticals market in Finland 2007-2016
- Share value of the generic pharmaceuticals market in Italy 2006-2017
- Share value of the generic pharmaceuticals market in Norway 2000-2017
- Production in European pharmaceutical industry by country 2016
- Members of EFPIA's pharmaceutical exports and imports 1990-2017
- Members of EFPIA's pharmaceutical market value 1990-2017
- Pharmacy market sales' parallel import share - European countries 2016
- Market share of specialty pharmaceuticals in selected regions 2008 and 2013
- United Kingdom (UK): pharmaceutical products export value to Germany 2012-2017
- Argentina: genitourinary system & sexual hormones market revenue 2017-2018
- United Kingdom (UK): pharmaceutical products import value from Slovakia 2012-2017
- Main importers of pharmaceutical products from the United Kingdom (UK) 2016-2017
- Lipid-modifying agents pharmaceutical consumption in Spain 2004-2014
Studies
- CDER New Drugs Program: 2018 Update
- CDER 2018 New Drug Therapy Approvals
- Pharmaceutical trends in Europe
- CDER 2017 New Drug Therapy Approvals
- CDER New Drugs Program: 2017 Update
- Pharmaceutical industry in the Netherlands
- CDER New Drug Review: 2016 Update
- Top 200 Products in the US Market by Sales, 2009
Statistics on "Pharmaceutical trends in Europe"
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)
- Share of breakdown of pharmaceutical price structure in Europe in 2016*
- Value Added Tax (VAT) rate on over-the-counter (OTC) drugs in Europe in 2018, by country*
- Value Added Tax (VAT) rate on prescription-only drugs in Europe in 2018, by country
- Share of GDP expenditure on research and development in the EU-28 countries from 2000 to 2015*
- Pharmaceutical research and development spending in selected European countries in 2016 (in million euros)
- Annual growth of pharmaceutical R&D spending in Europe and the U.S. between 2003 and 2017
- Market share of generics in selected European countries as of 2016
- Leading 18 European pharmaceutical companies by retail sales in 2015 (in billion U.S. dollars)
- Leading pharmaceutical and biotechnology companies in Europe in 2015, based on market value (in million U.S. dollars)
- Leading European pharmaceutical companies by spending on research and development in 2015 (in million U.S. dollars)
- Leading European pharmaceutical companies by investment in research and development in 2014 (in million U.S. dollars)
- Pharmaceutical production value of EFPIA members from 1990 to 2017 (in million euros)
- Pharmaceutical research and development spending of EFPIA members from 1990 to 2017 (in million euros)
- Sales in the self-medication market in selected European countries in 2017 (in million euro)
- Sales of analgesics in the self-medication market in Europe in 2017, by country (in million euro)
- Sales of cough and cold products in the self-medication market in Europe in 2017, by country (in million euro)
- Sales of digestives and intestinal remedies in the self-medication product market in Europe in 2017, by country (in million euro)
- Sales of self-medication skin treatment products in Europe in 2017, by country (in million euros)
- Sales of vitamin and mineral products in the self medication market in Europe in 2017, by country (in million euro)
- Market value of self-medication drugs in Italy from 2014 to 2017 (in million euros)
- Sales revenue of self-care medicines in the Netherlands in 2017, by purchase channel (in million euros)
- Sales revenue of self-care medicines in supermarkets in the Netherlands in 2017, by product segment (in million euros)
- Pharmaceutical employment in selected European countries in 2016
- Total pharmaceutical employment in EFPIA countries from 1990 to 2017
- Employment in pharmaceutical products and preparations manufacturing in the United Kingdom from 2008 to 2017 (in 1,000s)
- Number of employees in biotechnology companies, split by private or public sector in Switzerland from 2012 to 2017
- Number of employees in the pharmaceutical industry in Germany from 2010 to 2016
- Number of employees in the pharmaceutical industry in Belgium from 2014 to 2017
- Number of employees of pharmaceutical companies in France in 2014, by region of residence
- Number of employees in the pharmaceutical industry in Italy between 2000 and 2017
- Distribution of European clinical and phase III pipeline in 2013, by indication
- Number of clinical trials submitted to the European Medicines Agency from European countries from 2005 to 2011
- Number of patients per clinical trial in selected European countries from 2005 to 2011
- Number of applications to conduct a clinical trial submitted to BfArM and PEI* in Germany from 2009 to 2017
- Number of clinical trials authorized by the competent authority in Italy from 2003 to 2017
- Revenue of generic pharmaceutical manufacturing (NAICS 32541b) in the United States from 2008 to 2013 (in billion U.S. dollars)
- Market value share of generic pharmaceuticals in Portugal from 2000 to 2017
- Market share of generic pharmaceuticals in Czechia from 2001 to 2016
- Market value share of generic pharmaceuticals in Slovakia from 2000 to 2015
- Market value share of generic pharmaceuticals in Switzerland from 2000 to 2017
- Market share of generic pharmaceuticals in Turkey from 2008 to 2016
- Value share of the generic pharmaceuticals market in Estonia from 2006 to 2017
- Market value share of generic pharmaceuticals in Finland from 2007 to 2016
- Market value share of generic pharmaceuticals in Italy from 2006 to 2017
- Market share of generic pharmaceuticals in Norway from 2000 to 2017
- Pharmaceutical production in selected European countries in 2016 (in million euros)
- Pharmaceutical imports and exports of EFPIA members from 1990 to 2017 (in million euros)
- Pharmaceutical market value of EFPIA members from 1990 to 2017 (in million euros)
- Share of parallel imports in pharmacy market sales in selected European countries in 2016
- Specialty pharmaceuticals share of total pharma market in 2008 and 2013, by world region
- Value of pharmaceutical products exported from the United Kingdom (UK) to Germany from 2012 to 2017 (in million U.S. dollars)
- Revenue of the genitourinary system and sexual hormones pharmaceuticals market in Argentina from 1st quarter 2017 to 2nd quarter 2018 (in million Argentine pesos)
- Value of pharmaceutical products imported into the United Kingdom (UK) from Slovakia from 2012 to 2017 (in thousand U.S. dollars)
- Main countries importing pharmaceutical products from the United Kingdom (UK) in 2016 and 2017 (in thousand British pounds)
- Consumption of lipid-modifying agents per 1,000 inhabitants per day in Spain from 2004 to 2014
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account |
Instant Access
Premium Account | ||
|---|---|---|---|
Our servicesClick the question mark for further information | Free |
$49 per month* | |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.